AzTrials
AzTrials

Postoperative DepressionNCT07359170

Delivery Mode Impact on Postoperative Depression

An observational study of Postoperative Depression, run by Jingping Wang, MD, Ph.D..

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational retrospective cohort study is to examine the association between mode of delivery and early postpartum depressive symptoms in adult women who delivered at Massachusetts General Hospital. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Postoperative Depression
How many people
4,000 participants
Where
No sites listed yet
Study dates
15 Oct 2026to 28 Dec 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Study population: adult patients (≥18 years old) who underwent cesarean delivery or vaginal delivery

Who may be able to join

  • Underwent cesarean delivery (elective or emergency) or vaginal delivery during the study period
  • Age 18 years or older
  • Completed at least one Edinburgh Postnatal Depression Scale (EPDS) assessment at 6-8 weeks postpartum
  • Have complete perioperative data available

Who cannot join

  • Missing 6-8 week postpartum EPDS scores
  • Pregnancy with fetal demise, severe obstetric complications, or atypical maternal conditions
  • History of severe psychiatric disorders (e.g., schizophrenia, bipolar disorder), when identifiable
  • Incomplete perioperative medical records

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Jingping Wang, MD PhD contact

6179369136

jwang23@mgh.harvard.edu

About this study

Official title: Impact of Elective Versus Emergency Cesarean Delivery on Early Postpartum Depression: a Retrospective Study

The goal of this observational retrospective cohort study is to examine the association between mode of delivery and early postpartum depressive symptoms in adult women who delivered at Massachusetts General Hospital. Specifically, the study evaluates whether the urgency of cesarean delivery (elective versus emergency) is associated with differences in Edinburgh Postnatal Depression Scale (EPDS) scores at 6-8 weeks postpartum, compared with elective cesarean delivery and vaginal delivery. The EPDS is a validated 10-item self-report questionnaire with scores ranging from 0 to 30, where higher scores indicate more severe depressive symptoms.

The primary questions are whether EPDS scores differ among women undergoing emergency cesarean delivery, elective cesarean delivery, and vaginal delivery, and whether perioperative and obstetric factors are associated with postpartum depressive symptoms.

This study involves retrospective analysis of de-identified electronic health record data. Participants will not undergo any study-specific interventions.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07359170
Study groupRoleWhat they receive
elective cesareanpatients who undergone elective cesarean
urgent cesareanpatients undergone urgent cesarean
vaginal deliverypatients who delivered by vaginal pass

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Edinburgh Postnatal Depression Scale (EPDS) scores, a 10-item self-reported screening tool for postpartum depression (range: 0-30, with higher scores indicating more severe depressive symptoms)

    Measured: 6-8 weeks postpartum

Secondary outcomes (1)
  1. Prevalence of postpartum depression

    Prevalence of postpartum depression (EPDS ≥ threshold) across delivery groups.

    Measured: 6-8weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jan 2026
  2. Study start15 Oct 2026 (estimated)
  3. Primary completion28 Oct 2027 (estimated)
  4. Study completion28 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
4,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07359170
Sponsor's protocol ID
2025P002461
Status last verified
Jan 2026
First submitted
14 Jan 2026
Last updated
9 Jun 2026
Results posted
No

Questions about this trial

What is this clinical trial studying?

An observational study of Postoperative Depression, run by Jingping Wang, MD, Ph.D..

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 9 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jingping Wang, MD PhD (6179369136, jwang23@mgh.harvard.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Edinburgh Postnatal Depression Scale (EPDS) scores, a 10-item self-reported screening tool for postpartum depression (range: 0-30, with higher scores indicating more severe depressive symptoms) (time frame: 6-8 weeks postpartum). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in